New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
15:27 EDTSYKMariel Therapeutics to acquire Stryker's BMP-7 assets
Mariel Therapeutics announced that it has entered into a definitive agreement to acquire Stryker Corporation's Bone Morphogenetic Protein-7, or BMP-7, assets for the potential treatment of osteoarthritis, chronic kidney disease and other organ fibrosis conditions, lupus, and obesity. Under the terms of the agreement, Mariel acquired the rights to over 450 issued and pending patents, Stryker's BMP-7-related clinical and research data, and the associated biologic materials. Stryker will have a right of first negotiation for commercial rights in the area of osteoarthritis. Financial terms of the transaction were not disclosed.
News For SYK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
10:15 EDTSYKMarathon Patent unit gets favorable early ruling of infringement of '260 patent
Marathon Patent Group (MARA) announced that on July 1, in the patent infringement action filed by its wholly-owned subsidiary, MedTech Development Deutschland GmbH involving the patent EP 1 104 260 B2 the Munich District Court of Germany expressed in its preliminary opinion that the following defendants, Joline GmbH & Co. KG, Signus Medizintechnik GmbH and PanMedical, infringe the '260 patent. The '260 patent had previously been accused of invalidity by Stryker GmbH & Co. KG (SYK). In a nullity hearing held June 19, the five-judge panel at the Federal Patent Court, after carefully considering all facts and arguments brought by Stryker, deliberated and returned with the unrestricted verdict that "All claims are valid."
June 22, 2015
07:43 EDTSYKStryker management to meet with Deutsche Bank
Meeting to be held in Paris on June 22 hosted by Deutsche Bank.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use